Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection.
Granberg, K.L., Yuan, Z.Q., Lindmark, B., Edman, K., Kajanus, J., Hogner, A., Malmgren, M., O'Mahony, G., Nordqvist, A., Lindberg, J., Tangefjord, S., Kossenjans, M., Lofberg, C., Branalt, J., Liu, D., Selmi, N., Nikitidis, G., Nordberg, P., Hayen, A., Aagaard, A., Hansson, E., Hermansson, M., Ivarsson, I., Jansson-Lofmark, R., Karlsson, U., Johansson, U., William-Olsson, L., Hartleib-Geschwindner, J., Bamberg, K.(2019) J Med Chem 62: 1385-1406
- PubMed: 30596500 
- DOI: 10.1021/acs.jmedchem.8b01523
- Primary Citation of Related Structures:  
6GEV, 6GG8, 6GGG - PubMed Abstract: 
The mechanism-based risk for hyperkalemia has limited the use of mineralocorticoid receptor antagonists (MRAs) like eplerenone in cardio-renal diseases. Here, we describe the structure and property-driven lead generation and optimization, which resulted in identification of MR modulators ( S)-1 and ( S)-33 ...